Breast Cancer News and Research

Latest Breast Cancer News and Research

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Cancer survivors often describe their experience as a "journey." Now Nancy Parker, veteran corporate executive and breast cancer survivor, is taking other survivors on a more joyful journey. Her company, Travel Toward Wellness, is filling a unique travel niche, specializing in girlfriend getaways and women's wellness travel for cancer survivors.

23 Apr 2010

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.

23 Apr 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.

23 Apr 2010

Florida's Health Care Freedom Act receives approval

Today, Florida's Health Care Freedom Act (HJR 37/SJR 72), sponsored by Florida Representative Scott Plakon and Florida Senator Carey Baker, passed the House and Senate and will appear on the November ballot. And yesterday, Mississippi Representatives Alex Monsour and Steven Palazzo received preliminary approval to place the Health Care Freedom Act on the 2011 or 2012 ballot.

23 Apr 2010

Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Cancer Research

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a research paper describing the biological activity of its HDAC, EGFR and HER2 inhibitor, CUDC-101, was published online in the journal Cancer Research and also will be published in an upcoming print version of the journal.

23 Apr 2010

Report: Wellpoint targets breast cancer patients with policy rescissions

Reuters, in an exclusive report about the insurance industry practice of rescission: "That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. Insurance companies have used the practice.

23 Apr 2010

Aragon Pharmaceuticals raises $22M through Series B financing

Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing.

23 Apr 2010

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

The Helen F. Graham Cancer Center at Christiana Care is the recipient of $2.8 million from the National Cancer Institute, part of the National Institutes of Health, to expand cancer research.

22 Apr 2010

Increase in mammographic density associated with increase of breast cancer in EPT study participants

An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.

22 Apr 2010

AstraZeneca HealthCare Foundation's cardiovascular health program receives $25M charitable contribution

The AstraZeneca HealthCare Foundation announced today it received a $25 million charitable contribution from AstraZeneca for Connections for Cardiovascular Health(SM), its newest program with the mission of improving cardiovascular health in the United States.

22 Apr 2010

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Manhattan Scientifics, Inc. announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.

22 Apr 2010

Study links mutations in RAD51C gene to breast and ovarian cancer

The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.

22 Apr 2010

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Women who have a breast density of 75 percent or higher on a mammogram have a risk of breast cancer that is four to five times greater than that of women with little or no density, making mammographic breast density one of the strongest biomarkers of breast cancer risk.

22 Apr 2010

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.

21 Apr 2010

Investment report on Array BioPharma

MicroStockProfit.com announces an investment report featuring Array BioPharma Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Apr 2010

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.

21 Apr 2010

EGFR levels may help early detection of breast cancer

Levels of epidermal growth factor receptor (EGFR) may be elevated in the blood of women within 17 months prior to their breast cancer diagnosis, according to findings presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here April 17-21.

21 Apr 2010

Findings may illuminate how cancer forms and migrates

Rho proteins have been described as "molecular switches" and play a role in cell migration, cell proliferation, cell death, gene expression, and multiple other common cellular functions.

21 Apr 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Florida's Health Care Freedom Act receives approval

Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Cancer Research

Report: Wellpoint targets breast cancer patients with policy rescissions

Aragon Pharmaceuticals raises $22M through Series B financing

Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer research

Increase in mammographic density associated with increase of breast cancer in EPT study participants

AstraZeneca HealthCare Foundation's cardiovascular health program receives $25M charitable contribution

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Study links mutations in RAD51C gene to breast and ovarian cancer

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells

Investment report on Array BioPharma

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

EGFR levels may help early detection of breast cancer

Findings may illuminate how cancer forms and migrates

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in